Track topics on Twitter Track topics that are important to you
2410 Lillyvale Ave
United States of America
Phone: 888-GRIFOLS (888-474-3657)
Spanish drugmaker Grifols has reported first-quarter 2018 financial results, with 1.02 billion euros…
The FDA has granted Grifols clearance for the Procleix Ultrio Elite, a test designed to screen for hepatitis B, hepatitis C a -More-
Spanish drugmaker Grifols has announced a new collaboration agreement with IrsiCaixa AIDS Research Institute.
The FDA approved Grifols' HyperRAB, or rabies immune globulin, 300 IU/mL as a treatment for patients exposed to rabies virus -More-
Chinese biotechnology company Guanhao Biotech has agreed to purchase a 70% stake in Beihao Stem Cell and Regenerative Medicine Research...Read More... The post M&As this week: Guanhao Biotech, San...
Further evidence is required to warrant approval according to the US regulator
Albumin (Human) U.S.P. Human Albumin Grifols 25%
Albumin (Human) U.S.P. Human Albumin Grifols 20%
These highlights do not include all the information needed to use Albutein 5% safely and effectively. See full prescribing information for Albutein 5%. Albutein 5% [Albumin (Human) U.S.P.] sterile, aq...
These highlights do not include all the information needed to use Albutein 20% safely and effectively. See full prescribing information for Albutein 20%. Albutein 20% [Albumin (Human) U.S.P.] sterile,...
These highlights do not include all the information needed to use Albutein 25% safely and effectively. See full prescribing information for Albutein 25%.Albutein 25% [Albumin (Human) U.S.P.] sterile, ...
The purpose of this study is to evaluate the safety and hemostasis effectiveness of human plasma-derived fibrin sealant Grifols (FS Grifols) in peripheral vascular surgery.
This is a prospective, randomized, active-controlled, single-blind, parallel group clinical trial to evaluate the safety and efficacy of FS Grifols as an adjunct to hemostasis during surge...
This purpose of this clinical trial is to study the safety and efficacy of Topical Thrombin (Human) Grifols as an add-on treatment to help stop bleeding during vascular, parenchymous tissu...
The purpose of this study is to determine whether IGIV3I 10% Grifols is effective in the treatment of immune thrombocytopenic purpura.
Idiopathic (immune) thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by platelet destruction and thrombocytopenia (peripheral blood platelet count < 150 x 10(9)/L). ...
Grifols Biomat USA is part of a large a network of plasma collection centers owned and operated by Grifols, a global healthcare company headquartered in Barcelona, Spain. Today, Grifols' plasma t...
Grifols has been present in the field of healthcare since 1940 creating innovative products and services based on the values of ethics and responsibility. Over the decades, Grifols has contributed sig...
Grifols S.A. is a Spain-based company in the healthcare sector involved in the research, development, manufacturing and marketing of plasma therapies, IV therapy solutions, enteral and parenteral nutr...
Currently, we supply plasma products, diagnostic reagents, automated analyzers and dosing machines.In 1998, Grifols established a joint venture with a US diagnostic company, Quest International. Then,...
We have published hundreds of Grifols news stories on BioPortfolio along with dozens of Grifols Clinical Trials and PubMed Articles about Grifols for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Grifols Companies in our database. You can also find out about relevant Grifols Drugs and Medications on this site too.
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...
Bioethics is the study of controversial ethics brought about by advances in biology and medicine. Bioethicists are concerned with the ethical questions that arise in the relationships among life sciences, biotechnology, medicine, politics, law, and philo...